Post-recovery enhancement of anti-variant neutralisation after severe COVID-19

Yingying Lu; Yufang Zhu; Miao Cui; Zhengjiang Cheng; Peng Hong

doi:10.1016/S2666-5247(22)00032-5

Post-recovery enhancement of anti-variant neutralisation after severe COVID-19

Yingying Lu (Co-first Author), Yufang Zhu (Co-first Author), Miao Cui, Zhengjiang Cheng, Peng Hong^*

^*Corresponding author for this work

Department of Biomedical Sciences

Research output: Journal Publications and Reviews › Letter

3 Citations (Scopus)

49 Downloads (CityUHK Scholars)

Original language	English
Pages (from-to)	e330-e331
Journal	The Lancet Microbe
Volume	3
Issue number	5
Online published	7 Feb 2022
DOIs	https://doi.org/10.1016/S2666-5247(22)00032-5
Publication status	Published - May 2022

Publisher's Copyright Statement

This full text is made available under CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access Output

10.1016/S2666-5247(22)00032-5

104622840.pdfFinal Published version, 50.7 KBLicence: CC BY-NC-ND

Other Access Options

Check CityUHK Library

Permanent Link

Right click to copy link

Cite this

@article{53272a9a49a341439dbe83fcfebcab22,

title = "Post-recovery enhancement of anti-variant neutralisation after severe COVID-19",

author = "Yingying Lu and Yufang Zhu and Miao Cui and Zhengjiang Cheng and Peng Hong",

year = "2022",

month = may,

doi = "10.1016/S2666-5247(22)00032-5",

language = "English",

volume = "3",

pages = "e330--e331",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd.",

number = "5",

}

TY - JOUR

T1 - Post-recovery enhancement of anti-variant neutralisation after severe COVID-19

AU - Lu, Yingying

AU - Zhu, Yufang

AU - Cui, Miao

AU - Cheng, Zhengjiang

AU - Hong, Peng

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85127479059&partnerID=8YFLogxK

UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-85127479059&origin=recordpage

U2 - 10.1016/S2666-5247(22)00032-5

DO - 10.1016/S2666-5247(22)00032-5

M3 - Letter

C2 - 35156067

SN - 2666-5247

VL - 3

SP - e330-e331

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 5

ER -

Post-recovery enhancement of anti-variant neutralisation after severe COVID-19

Publisher's Copyright Statement

UN SDGs

Access Output

Other Access Options

Permanent Link

Other Files and Links

Cite this